Top US Generics Players Thwarted On August At-Risk Launch Of Fingolimod

 
• By Aidan Fry
  
Injunction
Leading US generics players have been hit by an injunction preventing launch of fingolimod pending trial over a dosage regimen patent • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin